News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,572 Results
Type
Article (15795)
Company Profile (71)
Press Release (267706)
Section
Business (83001)
Career Advice (2481)
Deals (13434)
Drug Delivery (50)
Drug Development (32597)
Employer Resources (112)
FDA (8696)
Job Trends (8031)
News (142239)
Policy (14170)
Tag
Academia (1570)
Africa (494)
Alliances (20788)
Alzheimer's disease (482)
Approvals (8669)
Arizona (49)
Artificial intelligence (33)
Asia (13239)
Australia (2509)
Bankruptcy (108)
Best Places to Work (6777)
Biotechnology (44)
C2C Services and Suppliers (33862)
California (651)
Canada (354)
Cancer (147)
Career advice (2048)
Cell therapy (31)
China (34)
Clinical research (26570)
Collaboration (48)
Colorado (40)
COVID-19 (1043)
Cystic fibrosis (30)
Data (66)
Diabetes (71)
Diagnostics (3701)
Diversity, equity & inclusion (33)
Drug pricing (43)
Earnings (25350)
Employer resources (99)
Europe (33645)
Events (39932)
Executive appointments (69)
FDA (8781)
Florida (118)
Funding (34)
Gene therapy (30)
GLP-1 (429)
Government (2501)
Healthcare (12072)
Hotbed/Location (196595)
Idaho (30)
Illinois (157)
Indiana (87)
Infectious disease (1049)
Inflammatory bowel disease (36)
Interviews (416)
IPO (5386)
Job creations (1289)
Job search strategy (1769)
Kansas (39)
Layoffs (130)
Legal (2576)
Liver cancer (30)
Lung cancer (33)
Management (35)
Manufacturing (36)
Maryland (166)
Massachusetts (495)
Medical device (7810)
Medtech (7810)
Mergers & acquisitions (8008)
Metabolic disorders (203)
Michigan (60)
Minnesota (71)
Neuroscience (519)
New Hampshire (34)
New Jersey (201)
New York (174)
NextGen Class of 2024 (4044)
Non-profit (3621)
North Carolina (344)
Northern California (336)
Now hiring (27)
Obesity (124)
Ohio (38)
Opinion (92)
Pennsylvania (199)
People (30019)
Phase I (6304)
Phase II (11154)
Phase III (10738)
Pipeline (44)
Postmarket research (1440)
Preclinical (2256)
Rare diseases (47)
Real estate (1936)
Recruiting (40)
Regulatory (9527)
Research institute (1386)
Resumes & cover letters (417)
South America (694)
Southern California (252)
Startups (1321)
Texas (86)
United States (3292)
Vaccines (112)
Washington State (87)
Weight loss (115)
Date
Last 7 days (198)
Last 30 days (1034)
Last 365 days (17173)
2024 (11320)
2023 (18169)
2022 (24258)
2021 (25915)
2020 (27359)
2019 (25659)
2018 (19073)
2017 (14085)
2016 (13946)
2015 (15397)
2014 (11133)
2013 (8799)
2012 (9713)
2011 (10193)
2010 (9021)
283,572 Results for "ascensia diabetes care".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
February 6, 2024
·
8 min read
Pharm Country
Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
Ascensia Diabetes Care and Senseonics Holdings, Inc. have launched a new U.S. advertising and marketing campaign for Eversense® E3 CGM System.
October 9, 2023
·
4 min read
Business
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Senseonics Holdings, Inc. in partnership with our global commercial partner, Ascensia Diabetes Care, and St. Louis-based Mercy, a leading health care system and accountable care organization, announced a first-of-its-kind relationship in a diabetes population management program.
May 13, 2024
·
8 min read
Business
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointment of Jean-Claude “JC” Kyrillos as Executive Vice President and Chief Operating Officer, effective June 21, 2024.
June 20, 2024
·
3 min read
Biotech Beach
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced its schedule of presentations for the American Diabetes Association’s 84th Scientific Sessions taking place in Orlando, Florida from June 21-24.
June 18, 2024
·
8 min read
Pharm Country
Ascensia Diabetes Care Collaborates With SNAQ to Support Mealtime Decision-Making for People With Diabetes
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes.
February 21, 2023
·
2 min read
Pharm Country
Ascensia Diabetes Care Expands Payment Assistance and Simple Savings Program for Eversense E3 CGM System
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring System portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has significantly expanded Eversense PASS, a Payment Assistance and Simple Savings program designed to enhance affordability and access to the Eversense E3 CGM System.
May 9, 2023
·
3 min read
Drug Development
Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Diabetes Care, the peer-reviewed journal of the American Diabetes Association, has published a research paper on the company’s Phase 2 RELIEF-DPN-1 clinical trial investigating LX9211 for the treatment of diabetic peripheral neuropathic pain (DPNP).
June 19, 2024
·
5 min read
Biotech Beach
Tandem Diabetes Care Announces Upcoming Conference Presentation - May 23, 2024
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:00am Eastern Time.
May 23, 2024
·
1 min read
Pharm Country
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK
Ascensia Diabetes Care , a global diabetes care company, maker of the CONTOUR ® Blood Glucose Monitoring (BGM) system portfolio and exclusive distributor of Eversense ® Continuous Glucose Monitoring (CGM) Systems, marks the one-year anniversary of launching Eversense ® E3 in the U.S. with a commercial update and outlook on future innovation.
April 24, 2023
·
4 min read
1 of 28,358
Next